Join the European Phage Therapy Consortium
In the context of the Horizon Europe 2025 Health Work Programme, a major opportunity is open under the call HORIZON-HLTH-2025-01-DISEASE-01:
“Testing safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections.”
We are launching the Phage Therapy Task Force to build a credible, multidisciplinary consortium able to address this challenge and submit a competitive proposal.
🔗 Official EU Call – Page 42: Download PDF Here
Objective
Our goal is to:
• Identify and connect leading academic, clinical, industrial, and regulatory actors
• Facilitate the development of translational, GMP-compliant, and clinically validated phage therapies
• Prepare a strong, high-impact submission under Horizon Europe 2025
Who Can Join?
We are looking for:
• Researchers in basic science, phage biology, or antibiotic resistance
• Clinical trial units or hospitals with capacity for implementation
• Biotech companies with GMP or preclinical capabilities
• Experts in regulatory affairs, AI modeling, or data science
• Translational innovation platforms and policy stakeholders
How to Apply
Please send a 1–2 page Expression of Interest to:
📩 [email protected]
Include:
• Name of your institution/team
• Contact person & email
• Field of expertise and services you offer
• Recent publications or funded projects
• Role you can play (e.g., WP leader, data coordinator, clinical PI)
🗓 Deadline: 15 August 2025
Additional Opportunity: A Coordinating Team is needed
We are actively seeking a team or company capable of coordinating and managing the Horizon Europe submission. If you are ready to take on this challenge, please contact us with details of your background, experience, honorarium, and availability.
Let’s advance the future of phage therapy together.
